Cannabix Technologies Develops Beta 2.0 Marijuana
Breathalyzer
Cannabix Hand-held THC Marijuana Breathalyzer is being developed
to give law enforcement and employers the ability to test for
recent consumption of the THC component of marijuana.
Vancouver, British Columbia -- October 19, 2016 -- InvestorsHub
NewsWire -- Cannabix Technologies Inc. (CSE:
BLO) (OTC
PINK: BLOZF) (the Company) provides an update on the
development of its FAIMS (high-field asymmetric waveform ion
mobility spectrometry) based instrument for detection of trace
amounts of tetrahydrocannabinol (THC) from exhaled breath at the
roadside and in the workplace. The Company is pleased to report
that it has developed a Beta 2.0 (Cannabix Marijuana Breathalyzer)
device with major advances in the design and size of the
device, including: greater sensitivity, improved performance
by the square waveform generator. The current design includes
features to allow for the addition of a rechargeable battery and
touch screen and the device is approximately 10 times smaller than
the Beta 1.0 device announced in July. Preliminary lab tests of the
FAIMS device coupled with quadrupole ion trap mass spectrometry
have shown lower levels of detection for THC standards than were
achieved in past testing.
Scientific Testing for the FAIMS Cannabix Marijuana
Breathalyzer
Cannabix scientists are formulating a scientific protocol to
conduct live THC breath testing using the Beta 2.0 Cannabix
Marijuana Breathalyzer in the coming weeks. The scientific testing
will likely be conducted in Vancouver BC, Canada, where medical
marijuana users will be engaged to determine the accuracy of the
Beta 2.0 Cannabix Marijuana Breathalyzer to detect both smoked and
edible consumption of marijuana in human breath. The results of the
scientific tests will be used to prepare submissions for approval
of the Cannabix Marijuana Breathalyzer as a court-approved device
by the Minister of Justice in Canada and the National Highway and
Safety Authority in the United States.
Kal Malhi, President of Cannabix stated, Several states in the
U.S. are voting to legalize recreational marijuana on November 8,
2016 and the need for law enforcement to have a tool to gather
scientific evidence of marijuana impairment in drivers is becoming
an urgent need. Cannabix Technologies has been diligently working
on our Cannabix Marijuana Breathalyzer for approximately two years
and we are excited to be at the advanced stage and preparing a
device for law enforcement and employers to begin testing. We are
making excellent progress with the objective of having an accurate
and court accepted tool in the coming months.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a leader in marijuana breathalyzer
development for law enforcement and the workplace. Cannabix has
established breath testing technologies in the pursuit of bringing
durable, portable hand-held tools to market to enhance detection of
marijuana impaired driving offences on roads at a time when
marijuana is becoming legal in many global jurisdictions. Cannabix
is working to develop drug-testing devices that will detect THC-
the psychoactive component of marijuana that causes intoxication-
using breath samples. In particular, Cannabix is focused on
developing breath testing devices for detection of recent use of
THC, in contrast to urine testing for THC metabolite that requires
an invasive collection and reflects use days or even weeks earlier.
The devices will also be useful for other practical applications
such as testing employees in the workplace where intoxication by
THC can be hazardous.
We seek Safe Harbor.
On behalf of the Board of Directors
Rav Mlait
CEO
Cannabix Technologies Inc.
For further information, contact the Company's CEO, Rav Mlait
604-551-7831 email at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking information that
involves various risks and uncertainties regarding future events.
Such forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Companys plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (v) the ability of the Company to develop and
market its future product; and (vi) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing patent pending technologies licensed by
the Company will receive patent status by regulatory authorities.
The Company is not currently selling commercial breathalyzers.
Actual results and future events could differ materially from those
anticipated in such information. These and all subsequent written
and oral forward-looking information are based on estimates and
opinions of management on the dates they are made and are expressly
qualified in their entirety by this notice. Except as required by
law, the Company does not intend to update these forward-looking
statements.
7934 Government Road, Burnaby, B.C., V5A 2E2
Phone: (604) 551-7831 Fax: 604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com